Non-Hodgkin Lymphoma - Pipeline Review, H2 2012 New Report
Non-Hodgkin Lymphoma - Pipeline Review, H2 2012, provides an overview of the Non-Hodgkin Lymphoma therapeutic pipeline. This report provides information on the therapeutic development for Non-Hodgkin Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Non-Hodgkin Lymphoma. 'Non-Hodgkin Lymphoma - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured...
View full press release